Krsnaa Diagnostics Limited
All news and filings related to Krsnaa Diagnostics Limited.
View all news & filings- Medium impact
Krsnaa Diagnostics Limited receives income tax appellate orders for multiple assessment years.
Krsnaa Diagnostics received income tax appellate orders for AYs 2017-24. The aggregate disputed demand is ₹62.69 crore. Appeals for AYs 2017-20 were dismissed, while AYs 2021-24 were partly allowed. The company plans to appeal further at the ITAT.
Read the summary - Low impact
Krsnaa Diagnostics Announces AGM Newspaper Publication
Krsnaa Diagnostics Limited published newspaper advertisements on September 06, 2026, regarding its 16th Annual General Meeting. The ads confirm the dispatch of the Annual Report and AGM notice. Information is also available on the company's investor website.
Read the summary - Low impact
Krsnaa Diagnostics Announces 16th AGM on Sep 28, 2026, with E-voting from Sep 25-27
Krsnaa Diagnostics will hold its 16th Annual General Meeting on September 28, 2026. Members can e-vote from September 25 to September 27, 2026. The cut-off date for voting rights is September 21, 2026. The company also released its Annual Report and Business Responsibility and Sustainability Report for FY 2025-26.
Read the summary - Low impact
Krsnaa Diagnostics Announces 16th AGM Scheduled for September 28, 2026
Krsnaa Diagnostics Limited will hold its 16th Annual General Meeting on September 28, 2026, at 11:00 AM IST at its registered office in Pune. The announcement follows newspaper publications on September 2, 2026.
Read the summary - Low impact
Krsnaa Diagnostics Publishes Corrigendum to Postal Ballot Notice for Preferential Issue
Krsnaa Diagnostics Limited published a corrigendum to its postal ballot notice for a preferential issue of warrants. Advertisements appeared in Financial Express and Loksatta on August 29, 2026. The details will also be available on the company's investor website.
Read the summary - Medium impact
Krsnaa Diagnostics Issues Corrigendum to Postal Ballot Notice for Preferential Issue
Krsnaa Diagnostics issued a corrigendum to its Postal Ballot Notice regarding a preferential issue of share warrants. The notice clarifies details on post-issue shareholding, subscriber intentions, and control changes. E-voting concludes on September 17, 2026, with options for vote modification.
Read the summary - Medium impact
Krsnaa Diagnostics Receives Income Tax Rectification Order, Faces Additional Demand of ₹12.1 Crore
Krsnaa Diagnostics received an income tax rectification order for AY 2022-23, resulting in an additional demand of ₹12.1 crore. The revised payable amount is ₹31.73 crore. The company plans to file an appeal against this demand.
Read the summary - Medium impact
Krsnaa Diagnostics to raise ₹91.75 crore via preferential issue of warrants
Krsnaa Diagnostics plans to raise ₹91.75 crore via preferential issue of 16,21,000 warrants. The issue price is ₹566 per warrant. Investors include Mr. Rajendra Mutha and Krsnaa Diagnostics (Mumbai) Private Limited. Warrants are convertible within 18 months of allotment.
Read the summary - Medium impact
Krsnaa Diagnostics Q1 FY27 Earnings Call Transcript Released
Krsnaa Diagnostics reported Q1 FY27 revenue of ₹2,355 million, up 22% YoY. The company secured the Himachal Pradesh CT project and saw its retail business grow 64% YoY to ₹193 million. EBITDA was ₹588 million (25% margin), impacted by Rajasthan project ramp-up costs. Retail is expected to be EBITDA positive by Q2 FY27.
Read the summary - Medium impact
Krsnaa Diagnostics Announces Postal Ballot for Preferential Issue of Warrants
Krsnaa Diagnostics Limited is conducting a postal ballot for a preferential issue of 16,21,000 warrants convertible to equity shares. The warrants will be issued to promoters Mr. Rajendra Khivraj Mutha and Krsna Diagnostics (Mumbai) Private Limited. The notice was published on August 19, 2026.
Read the summary - Medium impact
Krsnaa Diagnostics to issue 16.21 Lakh Warrants to Promoter Group for ₹91.75 Cr
Krsnaa Diagnostics will issue up to 16.21 lakh warrants to its Promoter and Promoter Group for ₹91.75 crore. The warrants are convertible into equity shares at ₹566 each. Funds will be used for capital expenditure on diagnostic equipment and acquisitions. Shareholders will vote via e-voting from August 19 to September 17, 2026.
Read the summary - Low impact
Krsnaa Diagnostics Publishes Unaudited Financial Results for Q1 FY27
Krsnaa Diagnostics Limited published its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The results were advertised on August 15, 2026, in the Financial Express and Loksatta newspapers and will be available on the company's investor website.
Read the summary - Low impact
Krsnaa Diagnostics: Audio Recording of Earnings Call for Q1 FY27 Available
Krsnaa Diagnostics Limited has released the audio recording of its earnings conference call for the quarter ended June 30, 2026. The call took place on August 14, 2026. The recording is available on the company's website.
Read the summary - Medium impact
Krsnaa Diagnostics Presents Investor Presentation for Q1 FY27 Results
Krsnaa Diagnostics reported Q1 FY27 consolidated revenue of ₹2,355 million, up 22% YoY. Retail revenue surged 64% YoY to ₹118 million. PAT declined 19% to ₹166 million. The company is expanding its network and focusing on retail-led growth strategies.
Read the summary - Medium impact
Krsnaa Diagnostics Q1 FY27 Revenue up 22% to ₹2,355 million; Rajasthan ops live
Krsnaa Diagnostics reported Q1 FY27 revenue of ₹2,355 million, a 22% YoY increase. Rajasthan operations are now live, contributing ₹257 million. Retail revenue grew 64% YoY to ₹193 million. The Board approved a preferential warrant issue to promoters.
Read the summary - Medium impact
Krsnaa Diagnostics Board Approves Q1 FY27 Results, Recommends Dividend, Plans Warrants
Krsnaa Diagnostics reported Q1 FY27 results with consolidated revenue of ₹235.53 crore and standalone profit before tax of ₹540.32 million. The Board approved the Q1 FY27 results and recommended a final dividend of ₹2.00 per share. The 16th AGM is on September 28, 2026. The company will issue 16.21 lakh warrants to promoters at a price higher of ₹565 or floor price.
Read the summary - High impact
Krsnaa Diagnostics Board Approves Q1 FY27 Results, Declares ₹2 Dividend, Issues Warrants
Krsnaa Diagnostics approved Q1 FY27 results with consolidated revenue of ₹2,355.32 crore and profit after tax of ₹65.51 crore. A final dividend of ₹2.00 per share was recommended. The company will issue 16,21,000 warrants to promoters at a price higher than ₹565. The 16th AGM is on September 28, 2026.
Read the summary - Medium impact
Krsnaa Diagnostics Board Approves Q1 FY27 Results, Declares Dividend, Issues Warrants
Krsnaa Diagnostics approved Q1 FY27 unaudited results and declared a final dividend of ₹2.00 per share. The company will issue 16,21,000 warrants to promoters at a price determined by floor price or ₹565. The 16th AGM is scheduled for September 28, 2026.
Read the summary - Medium impact
Krsnaa Diagnostics Board Approves Q1 FY27 Results, Recommends ₹2 Dividend, Issues Warrants
Krsnaa Diagnostics approved Q1 FY27 results, reporting consolidated revenue of ₹235.53 crore and PAT of ₹65.51 lakh. Standalone revenue was ₹210.66 crore with PAT of ₹58.20 lakh. The company recommended a ₹2 final dividend and approved issuing 16.21 lakh warrants to promoters at a floor price of ₹565.
Read the summary - Medium impact
Krsnaa Diagnostics Board Approves Q1 FY27 Results, Recommends Final Dividend
Krsnaa Diagnostics approved Q1 FY27 results with consolidated revenue from operations at ₹235.53 crore and profit after tax of ₹65.51 lakh. The company approved issuing 16,21,000 warrants to promoters at a price higher of ₹565 or SEBI floor price. The 16th AGM is scheduled for September 28, 2026, with a record date of September 18, 2026, for a ₹2.00 per share final dividend.
Read the summary - Low impact
Krsnaa Diagnostics schedules Q1 FY27 earnings call for Aug 14, 2026
Krsnaa Diagnostics Limited will hold its Q1 FY27 earnings conference call on August 14, 2026, at 13:00 IST. Management will discuss financial results for the quarter ended June 30, 2026.
Read the summary - Medium impact
Krsnaa Diagnostics Expands Himachal Pradesh CT Scan Facilities to 34 Institutions
Krsnaa Diagnostics signed a PPP agreement with Himachal Pradesh health department to manage CT Scan facilities at 34 government institutions. This expands their services from 12 to 34 locations for an initial 7-year period, extendable by 3 years. The contract is largely cash-based.
Read the summary - Low impact
Krsnaa Diagnostics submits SEBI Regulation 74(5) certificate for Q1FY27
Krsnaa Diagnostics Limited submitted the confirmation certificate for Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. The certificate covers the quarter ended June 30, 2026, and confirms dematerialization/rematerialization details furnished to stock exchanges.
Read the summary - Medium impact
Krsnaa Diagnostics: ICRA Affirms Long-Term 'A' and Short-Term 'A1' Ratings
ICRA Limited has reaffirmed Krsnaa Diagnostics Limited's long-term rating at ICRA A (Stable) for ₹166.60 crore and short-term rating at ICRA A1 for ₹137.55 crore. The total rated bank facilities stand at ₹304.15 crore. The outlook on the long-term rating is Stable.
Read the summary - Low impact
Krsnaa Diagnostics: Trading Window Closed July 1 for Q1 FY27 Results
Krsnaa Diagnostics Limited will close its trading window from July 1, 2026, until 48 hours after the declaration of Q1 FY27 unaudited financial results. This is to comply with SEBI insider trading regulations. All designated persons and promoters are restricted from trading securities during this period.
Read the summary - Low impact
Krsnaa Diagnostics Publishes Newspaper Advertisement for Postal Ballot Notice
Krsnaa Diagnostics Limited published newspaper advertisements on June 04, 2026, for a Postal Ballot notice. Members will vote on proposed resolutions via e-voting. The notice is compliant with SEBI LODR Regulations and the Companies Act, 2013.
Read the summary - Medium impact
Krsnaa Diagnostics Seeks Shareholder Approval for Director Appointments and Director Remuneration
Krsnaa Diagnostics is seeking shareholder approval via postal ballot for director re-appointments and remuneration. Key proposals include re-appointing Chetan Desai as Independent Director for five years and appointing Raju Venkatraman and Lilian Jessie Paul for two years. Shareholders will also vote on a commission payment to Independent Directors, capped at ₹50 Lakhs annually. E-voting is open from June 5 to July 4, 2026.
Read the summary - Medium impact
Krsnaa Diagnostics Releases Q4 FY26 Earnings Call Transcript
Krsnaa Diagnostics released its Q4 FY26 earnings call transcript. For FY26, revenues were ₹7,728 million and PAT was ₹1,014 million. The company plans ₹5,000 million capex for FY27 and has ₹6,000-7,000 crores revenue visibility over 5-7 years. A dividend of ₹2 per share was recommended. Rajasthan operations are expected to start contributing from Q1 FY27.
Read the summary - Low impact
Krsnaa Diagnostics Publishes Audited Financial Results for Q4 FY26 in Newspapers
Krsnaa Diagnostics Limited published its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The advertisements appeared in the Financial Express and Loksatta on May 27, 2026.
Read the summary - Low impact
Krsnaa Diagnostics Publishes Audited Financial Results for FY26 Q4
Krsnaa Diagnostics Limited published its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. Advertisements appeared on May 27, 2026, in Financial Express and Loksatta. Results will be available on the company's investor website.
Read the summary - Low impact
Krsnaa Diagnostics Releases Audio Recording of Earnings Call for Q4 FY26
Krsnaa Diagnostics Limited has released the audio recording of its earnings conference call for the quarter and year ended March 31, 2026. The call took place on May 26, 2026. The recording is available on the company's website.
Read the summary - High impact
Krsnaa Diagnostics Q4 FY26 PAT Surges 102% to ₹417 Crore on Strong Revenue Growth
Krsnaa Diagnostics reported a 102% surge in Q4 FY26 PAT to ₹417 crore, up from ₹207 crore in Q4 FY25. Revenue increased by 4% to ₹1,926 crore. For FY25-26, PAT rose 31% to ₹1,013 crore on 8% higher revenue of ₹7,728 crore. NABH accreditation for radiology centres grew significantly.
Read the summary - High impact
Krsnaa Diagnostics FY26 PAT Jumps 31% to ₹1,014 Million; Recommends ₹2 Dividend
Krsnaa Diagnostics reported FY26 consolidated revenue of ₹7,728 million and PAT of ₹1,014 million, up 31%. Diluted EPS was ₹30.88. Operating cash flows grew 64% to ₹1,431 million. The Board recommended a ₹2 per share final dividend.
Read the summary - Medium impact
Krsnaa Diagnostics Board Approves FY26 Results, Recommends 40% Final Dividend
Krsnaa Diagnostics reported audited standalone and consolidated financial results for FY26. The company recommended a final dividend of ₹2 per share. Key auditor appointments were also approved, including M/s Kirtane & Pandit LLP as Statutory Auditors for FY27-FY31.
Read the summary - Medium impact
Krsnaa Diagnostics recommends ₹2/share final dividend; approves FY26 results
Krsnaa Diagnostics approved FY26 audited financial results. Recommended a final dividend of ₹2 per equity share for FY26. Recommended appointment of M/s Kirtane & Pandit LLP as Statutory Auditors for FY27-FY31. Consolidated PAT was ₹1,014.31 million and standalone PAT was ₹1,026.75 million.
Read the summary - Medium impact
Krsnaa Diagnostics Approves FY26 Audited Results & Recommends 40% Final Dividend
Krsnaa Diagnostics Limited reported audited standalone and consolidated results for FY26. The company recommended a final dividend of ₹2 per share (40%). The Board approved the appointment of M/s Kirtane & Pandit LLP as Statutory Auditors for FY27-FY31.
Read the summary - Low impact
Krsnaa Diagnostics Schedules Q4FY26/FY26 Earnings Conference Call for May 26, 2026
Krsnaa Diagnostics will hold its Q4FY26/FY26 earnings conference call on May 26, 2026, at 12:30 PM IST. Management, including Chairman Mr. Rajendra Mutha and MD Mr. Yash Mutha, will participate. Dial-in details and registration links are provided. Transcript and audio will be uploaded post-call.
Read the summary - Low impact
Krsnaa Diagnostics Announces Post Earnings Conference Call on May 26, 2026
Krsnaa Diagnostics will hold a post-earnings conference call on May 26, 2026, at 12:30 Hrs (IST) to discuss the financial results for the quarter and year ended March 31, 2026. Following the discussion, there will be an interactive Q&A session. Conference call details will be shared later, and the transcript/audio will be on the company website.
Read the summary - Medium impact
Krsnaa Diagnostics faces ₹11.3 Crore tax demand for FY19-20.
Krsnaa Diagnostics Limited received assessment orders and demand notices for AY 2018-19 and 2019-20. The total income tax demand aggregates to ₹11.30 crore (₹4.03 crore for AY18-19 and ₹7.26 crore for AY19-20). The company has challenged the orders and expects no operational disruption.
Read the summary - Medium impact
Krsnaa Diagnostics Appoints New Directors, Interim CFO; Several Directors to Exit
Krsnaa Diagnostics appointed Mr. Raju Venkatraman and Ms. Lilian Jessie Paul as Independent Directors from April 25, 2026, for two years. Mr. Chetan Desai was re-appointed as Independent Director for five years from April 25, 2026. Mr. Chandra Prakash Singh is the new Interim CFO from April 17, 2026. Ms. Pallavi Bhatevara, Mr. Rajiva Ranjan Verma, and Ms. Chhaya Palrecha will exit their roles by April 25, 2026.
Read the summary - Medium impact
Krsnaa Diagnostics Appoints Two Independent Directors, Interim CFO; Three Directors Complete Tenure
Krsnaa Diagnostics appointed Mr. Raju Venkatraman and Ms. Lilian Jessie Paul as Independent Directors for two years from April 25, 2026. Mr. Chetan Desai was re-appointed as Independent Director for five years from April 25, 2026. Mr. Chandra Prakash Singh is the new Interim CFO from April 17, 2026. Three directors, including a Whole-time Director and two Independent Directors, will complete their tenures by April 25, 2026.
Read the summary - Medium impact
Krsnaa Diagnostics Appoints New Directors and Interim CFO, Reconstitutes Committees
Krsnaa Diagnostics appointed Mr. Raju Venkatraman and Ms. Lilian Jessie Paul as Independent Directors from April 25, 2026, for two years. Mr. Chetan Desai was re-appointed as Independent Director for five years. Mr. Chandra Prakash Singh appointed Interim CFO from April 17, 2026. Director tenures conclude April 24-25, 2026.
Read the summary - Medium impact
Krsnaa Diagnostics: Shareholders Approve Re-appointment of Executive Chairman
Krsnaa Diagnostics Limited shareholders approved the re-appointment of Mr. Rajendra Khivraj Mutha as Executive Chairman for five years. The Ordinary Resolution passed via postal ballot on April 16, 2026.
Read the summary - Medium impact
Krsnaa Diagnostics shareholders approve re-appointment of Executive Chairman
Krsnaa Diagnostics Limited shareholders have approved the re-appointment of Mr. Rajendra Khivraj Mutha as Executive Chairman for a five-year term. The ordinary resolution passed via postal ballot concluded on April 16, 2026, with the required majority.
Read the summary - Low impact
Krsnaa Diagnostics submits SEBI Reg 74(5) certificate for Q4 FY26
Krsnaa Diagnostics Limited submitted its SEBI Regulation 74(5) certificate for the quarter ended March 31, 2026. The certificate confirms dematerialization/rematerialization of securities as per SEBI regulations, furnished by the registrar KFin Technologies Limited.
Read the summary - Low impact
Krsnaa Diagnostics: Head-Investor Relations, Vivek Jain Resigns
Mr. Vivek Jain, Head-Investor Relations at Krsnaa Diagnostics Limited, has resigned due to personal reasons. His last working day will be March 31, 2026. The company acknowledged his contributions.
Read the summary - Low impact
Krsnaa Diagnostics: Trading Window Closed from April 1, 2026 for FY26 Audited Results
Krsnaa Diagnostics Limited will close its trading window from April 1, 2026, until 48 hours after the announcement of audited financial results for the quarter and fiscal year ending March 31, 2026. This measure aligns with SEBI's insider trading regulations.
Read the summary - Low impact
Krsnaa Diagnostics Publishes Postal Ballot Notice in Newspapers
Krsnaa Diagnostics Limited published a notice for a postal ballot in the Financial Express and Loksatta newspapers on March 17, 2026. The resolution will be passed via e-voting. The notice is available on the company's website.
Read the summary - Medium impact
Krsnaa Diagnostics seeks shareholder approval for re-appointment of Executive Chairman
Krsnaa Diagnostics Limited is seeking shareholder approval for the re-appointment of Mr. Rajendra Khivraj Mutha as Executive Chairman for five years, effective April 26, 2026. E-voting is scheduled from March 18 to April 16, 2026. His proposed annual salary is ₹2,64,00,000.
Read the summary - Low impact
Krsnaa Diagnostics to Meet Investors/Analysts on Feb 27
Krsnaa Diagnostics Limited will hold a one-on-one physical meeting with Omega Portfolio Advisors on February 27, 2026, in Pune. Discussions will be limited to publicly available information, with no unpublished price sensitive information to be disclosed.
Read the summary
Model portfolios
Filings are the raw material. These are what SEBI-registered experts build from them.
- Stocks
All-Terrain
One equity portfolio instead of three: large, mid and small cap in a single book.
Moderate-Aggressive34 holdings3+ yearsView portfolio - Stocks
Core Compounders
Companies that have already been through a downturn and came out still growing.
Moderate20 holdings3+ yearsView portfolio - Stocks
Udaan
Fast-growing, less-covered companies still early in their runway.
Aggressive29 holdings5+ yearsView portfolio - Stocks
Bharat Rising
Built around India's own shifts: capex, household savings, energy and consumption.
Moderate-Aggressive25 holdings3+ yearsView portfolio